Context and biological diversity
Osteosarcoma, Ewing sarcoma and chondrosarcoma are examples of distinct primary bone tumors. They should not be grouped with metastases from other organs to bone. Age, site, disease extent and pathological classification help delimit a question that can be answered consistently.
What research makes it possible to study
The TARGET osteosarcoma project brings together molecular profiles of pediatric tumors with clinical data and matched normal material. Tissue quality and availability criteria influenced selection. The resource allows study of somatic variants and progression hypotheses but does not automatically represent other bone sarcomas or all ages.
Application in a research project
A reproducible analysis can begin with cohort definition, recording the data version and excluding repeated samples from the same participant. Discovery and validation need to be separate. In addition to tumor outcomes, function, mobility and late effects may be relevant if measured with appropriate instruments and timing.
Research questions
Is a signature identified in osteosarcoma reproduced in an independent set of participants?
- Study design
- Discovery analysis in TARGET followed by external validation with a frozen pipeline and variables.
- What to measure
- Signature stability, prognostic performance, missing data and cohort characteristics.
- Interpretation limits
- Small series and selection of high-quality tissue limit generalization. Osteosarcoma signatures should not be transferred to Ewing sarcoma or chondrosarcoma.
Interpretation limits
Small series and selection of high-quality tissue limit generalization. Osteosarcoma signatures should not be transferred to Ewing sarcoma or chondrosarcoma.
Original references
Continue exploring
Educational content for framing research. Consult the original document, study population and methodology before interpreting a conclusion. Methodology